| Literature DB >> 30778732 |
Muris Humo1, Han Lu1,2, Ipek Yalcin3.
Abstract
The increasing number of individuals with comorbidities poses an urgent need to improve the management of patients with multiple co-existing diseases. Among these comorbidities, chronic pain and mood disorders, two long-lasting disabling conditions that significantly reduce the quality of life, could be cited first. The recent development of animal models accelerated the studies focusing on the underlying mechanisms of the chronic pain and depression/anxiety comorbidity. This review provides an overview of clinical and pre-clinical studies performed over the past two decades addressing the molecular aspects of the comorbid relationship of chronic pain and depression. We thus focused on the studies that investigated the molecular characteristics of the comorbid relationship between chronic pain and mood disorders, especially major depressive disorders, from the genetic and epigenetic point of view to key neuromodulators which have been shown to play an important role in this comorbidity.Entities:
Keywords: Behavior; Chronic pain; Depression; Molecular characteristics; Neuropathic pain
Mesh:
Substances:
Year: 2019 PMID: 30778732 DOI: 10.1007/s00441-019-03003-z
Source DB: PubMed Journal: Cell Tissue Res ISSN: 0302-766X Impact factor: 5.249